[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335487-105":59,"doc-detail-335487-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","regional-immune-mechanisms-enhance-efficacy-of-an-autologous-cellular-cancer-vaccine-with-intraperitoneal-administration","Regional immune mechanisms enhance efficacy of an autologous cellular cancer vaccine with intraperitoneal administration","","Widespread peritoneal dissemination is common in gynecologic and gastrointestinal cancers, motivating intraperitoneal immunotherapy. This study investigates immune mechanisms activated by intraperitoneal delivery of a cell-based vaccine of silicified ovarian cancer cells shown to enhance survival. Using bioluminescent and fluorescent imaging, microscopy, flow cytometry, and spectral flow cytometry, the work tracks vaccine trafficking to milky spots and fat-associated lymphoid clusters, profiles immune dependencies, and evaluates systemic tumor control in disseminated ovarian and colorectal cancer models.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/regional-immune-mechanisms-enhance-efficacy-of-an-autologous-cellular-cancer-vaccine-with-intraperitoneal-administration/335487/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/regional-immune-mechanisms-enhance-efficacy-of-an-autologous-cellular-cancer-vaccine-with-intraperitoneal-administration/335487.png","ImageObject",300,407,{"name":92,"@type":93},"Eden","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-07","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the vaccine and how is it administered in this study?","Question",{"text":112,"@type":113},"The study uses a cell-based vaccine made of silicified ovarian cancer cells and delivers it intraperitoneally to engage regional immune networks.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How do the researchers track immune trafficking and immune cell responses?",{"text":117,"@type":113},"Vaccine trafficking and cancer burden are assessed using bioluminescent and fluorescent imaging plus microscopy, while immune cell populations are phenotyped with flow cytometry and spectral flow cytometry.",{"name":119,"@type":110,"acceptedAnswer":120},"What immune mechanism is associated with tumor clearance?",{"text":121,"@type":113},"Tumor clearance in the models is confirmed to be T cell-mediated, supporting the establishment of local and systemic anti-tumor immunity.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},335487,1790745458,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},1374391974468,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","ORIGINAL RESEARCH     \nRegional immune mechanisms enhance efficacy of an autologous cellular cancer vaccine with intraperitoneal administration  \nBen Marwedela, Lorél Y. Medinaa, Henning De Mayb, Joshua E. Adoglaa, Ellie Kennedya, Erica Floresa, Eunju Lima, Sarah Adamsb, Eric Barteea, and Rita E. Serdaa  \naInternal Medicine, University of New Mexico Health Science Center, Albuquerque, NM, USA; bDepartment of Obstetrics & Gynecology, University of New Mexico Health Science Center, Albuquerque, NM, USA  \nABSTRACT  \nWidespread peritoneal dissemination is common in patients with gynecologic or gastrointestinal cancers. Accumulating evidence of a central role for regional immunity in cancer control indicates that intraperitoneal immunotherapy may have treatment advantages. This study delineates immune mechanisms engaged by intraperitoneal delivery of a cell-based vaccine comprised of silicified ovarian cancer cells associated with enhanced survival. Vaccine trafficking from the site of injection to milky spots and other fat-associated lymphoid clusters was studied in syngeneic cancer models using bioluminescent and fluorescent imaging, microscopy, and flow cytometry. Spectral flow cytometry was used to phenotype peritoneal immune cell populations, while bioluminescent imaging of cancer was used to study myeloid and T cell dependency, systemic immunity, and vaccine efficacy in models of disseminated high-grade serous ovarian and DNA mismatch-repair proficient microsatellite-stable colorectal cancer. Following intraperitoneal vaccination of mice with ovarian cancer, vaccine cells were rapidly internalized by myeloid cells, with subsequent trafficking to fat-associated lymphoid clusters. Tumor clearance was confirmed tobe T cell-mediated, leading to the establishment of local and systemic immunity. Combination immune checkpoint inhibitor and vaccine therapy in mice with advanced disease, characterized by an established suppressive tumor microenvironment, increased the number of mice with non-detectable tumors, however, change in tumor burden compared to vaccine monotherapy was not significant. Vaccination also resulted in tumor clearance in mouse models of metastatic colorectal cancer. This study demonstrates that intraperitoneal vaccine delivery has the potential to enhance vaccine efficacy by activating resident immune cells with the subsequent establishment of protective systemic anti-tumor immunity.  \nARTICLE HISTORY  \nReceived 10 June 2024 Revised 15 October 2024 Accepted 21 October 2024  \nKEYWORDS  \nCell silicification;  \nfat-associated lymphoid clusters; milky spots; Toll-like receptor agonists; vaccine  \nIntroduction  \nWe recently reported that cryo-silicified cancer cells can be used as a modular platform for highly effective personalized immune therapy.1,2 The thin, hydroxylated silicified cell surface enables modification with immunogenic molecules, including microbial based Toll-like receptor (TLR) agonists. These ligands activate signaling pathways in immune cells via TLRs present both on and within immune cells.3,4 Combination TLR4 and TLR9 activation restores antigen presenting functions of human ascites myeloid cells.5 When used as a cellular vaccine, TLR agonist-decorated silicified tumor cells achieved tumor clearance in mice with small volume disseminated disease and induced protective immune memory resulting in long-term disease-free survival. In these studies, intraperitoneal delivery was critical to achieving durable disease control in advanced models of high-grade ovarian cancer, suggesting that activation of resident immune cells can overcome treatment limitations attributed to the immune suppressive tumor microenvironment.2 Importantly, intraperitoneal treatment was also able to induce systemic immunity to control extraperitoneal disease. These results present a strategy to  \nengage regional immune networks to optimally deploy a novel and highly effective personalized cancer vaccine.6–8  \nOvarian, gastric, col","cbCaihFNHWOzxMvC","https://ap.wps.com/l/cbCaihFNHWOzxMvC","pdf",9991538,15,"English","# ABSTRACT\n# Introduction\n## Regional immunity and peritoneal dissemination\n## Milky spots and fat-associated lymphoid clusters\n## Immune activation and tumor microenvironment\n# ARTICLE HISTORY\n# KEYWORDS","[{\"question\":\"What is the vaccine and how is it administered in this study?\",\"answer\":\"The study uses a cell-based vaccine made of silicified ovarian cancer cells and delivers it intraperitoneally to engage regional immune networks.\"},{\"question\":\"How do the researchers track immune trafficking and immune cell responses?\",\"answer\":\"Vaccine trafficking and cancer burden are assessed using bioluminescent and fluorescent imaging plus microscopy, while immune cell populations are phenotyped with flow cytometry and spectral flow cytometry.\"},{\"question\":\"What immune mechanism is associated with tumor clearance?\",\"answer\":\"Tumor clearance in the models is confirmed to be T cell-mediated, supporting the establishment of local and systemic anti-tumor immunity.\"}]","Regional immune mechanisms enhance efficacy of an autologous cellular cancer vaccine with intraperitoneal administration | PDF",1790011134,38]